Cannabis Law Report

SEPTEMBER 14, 2021

Radicle Science disrupts the traditional clinical trial model by combining the reach of a market research company, the scientific rigor of a research university, and the agility of a tech company. About Radicle Science. Headquartered in Roxboro, N.C.,

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

JUNE 7, 2021

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Department of Agriculture (USDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final or conditional approval from the U.S.

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Essay: “The Nature of Hemp and Law: Hazy Regulation”. Jack Devanna . School: The University of Rhode Island.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

SEPTEMBER 2, 2021

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S.

Clinical Trials 99

Clinical Trials Research and Development Therapy Collective 99

Cannabis Law Report

NOVEMBER 15, 2021

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Applied DNA has also established a COVID-19 diagnostic and testing offering that is grounded in the Company’s deep expertise in DNA. Visit adnas.com for more information. Investor Contact: Sanjay M.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

OCTOBER 12, 2021

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S.

Programs 52

Programs Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JUNE 2, 2021

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S.

Clinical Trials 82

Clinical Trials Therapy Research and Development Collective 82

Cannabis Law Report

AUGUST 3, 2021

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. FDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S.

Clinical Trials 105

Clinical Trials Therapy Collective Research and Development 105

Cannabis Law Report

JULY 28, 2021

We look forward to providing continued updates on our intellectual property, research, clinical, regulatory and manufacturing activities for PD-001; our novel oral formulation of cepharanthine, with the aim of working towards a first-in-human, proof-of-concept clinical trial under an FDA IND approval.” ” Next Steps.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

JANUARY 24, 2022

In addition, as countries in the region are actively liberalizing laws related to marijuana, the market is likely to witness increased demand for cannabis-based products as well as their derivatives. North America Legal Cannabis Number of clinical trials. The marijuana segment dominated the market in 2021. Market Segmentation.

Legalization 52

Legalization Supply Chain Chronic Pain Recreational 52

Cannabis Law Report

SEPTEMBER 9, 2021

Global Legal Cannabis Industry: Number of Clinical Trials, By Region. Supply Chain Analysis. Supply Chain Analysis. Chapter 3 Global Legal Cannabis Market Variables, Trends & Scope. Market Segmentation. Penetration and Growth Prospect Mapping. Market Dynamics. Market Driver Analysis. The Netherlands.

Recreational 95

Recreational Hemp THC Legalization 95

Cannabis Law Report

DECEMBER 6, 2021

“We look forward to Jeff’s significant contributions heading into another year of continued growth and progress for Goldfinch Bio, including a planned interim data readout from TRACTION-2, the ongoing Phase 2 clinical trial of our lead precision kidney medicine candidate, in mid-2022.”.

Research and Development 52

Research and Development Supply Chain Clinical Trials Medicine 52

Canna Law Blog

MAY 7, 2020

for various studies, including FDA-approved clinical trials. These cannabis products are used by researchers in the U.S. In turn, the DEA knew in 2018 that it would need to engage in significant rule changes to remedy the issues pointed out in the OLC memo. The FOIA case was settled at the end of April of this year.

DEA 74

DEA Research and Development Cultivation Supply Chain 74

Cannabis Law Report

MARCH 25, 2020

(OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM ® Biotechnologies, Inc.

Research and Development 59

Research and Development Supply Chain Pharmaceutical Clinical Trials 59

Cannabis Law Report

SEPTEMBER 3, 2019

The laws allow concentrate-based medical cannabis to be prescribed in Australia for the treatment of a variety of specific illnesses. Global Supply Chain Platform. MediPharm Labs Australia is expected to serve as part of MediPharm Labs’ global supply chain platform and a springboard to serving the Asia-Pacific region.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. The Department is opposing the bill on grounds that it will create significant problems by bringing the state into conflict with federal laws designed to prevent money laundering.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

JULY 15, 2022

Federal Member for Fairfax Ted O’Brien said strict controls of the supply chain would be critical to the Government’s aspirations to make Australia the number one world player in medicinal cannabis. Most important to have your clinical trials based on the genetics of your plants. ADAM BENJAMIN: Absolutely.

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

NOVEMBER 7, 2019

chemovars) in house to ensure strict guidelines are followed to supply a consistent and clean medicinal product at low costs. With a strong focus on research and development ranging from agronomic research through to clinical trials Cannatrek has an extensive R&D portfolio from Seed to Patient.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

Cannabis Law Report

DECEMBER 21, 2021

Engaging in these markets required Dalrada’s perseverance to overcome continual supply chain delays created by the pandemic that is now in its second year. Payal Keswarpu, presented cerVIA™ clinical study results at the 17th World Congress for Cervical Pathology and Colposcopy before 42 participating countries.

Research and Development 52

Research and Development Supply Chain Data Business 52

Cannabis Law Report

OCTOBER 3, 2019

The regime establishes a strict ‘supply chain’ via the restrictions imposed on each licence restricting where, or to whom, the cannabis plant, drug or product can be supplied (‘permitted uses’). Importantly, the Final Report found that the complexity and rigidity of the regime is counterproductive.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40